Autoimmune Disease clinical trials at UCSF
2 in progress, 1 open to eligible people
An autoimmune disease is when the body's immune system attacks its own cells. UCSF is recruiting for trials on using cord blood units to treat these diseases. These trials are open for children and aim to study the effects of this treatment.
Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
open to all eligible people
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Oakland, California and other locations
IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
Sorry, not yet accepting patients
This is an open label, Phase 1b, multiple ascending dose, and dose-expansion study of IDP-023 administered in combination with interleukin-2 (IL-2) and ocrelizumab to evaluate the safety, tolerability, and biologic activity on autoreactive immune cells in patients with refractory progressive multiple sclerosis.
San Francisco, California and other locations
Our lead scientists for Autoimmune Disease research studies include Thomas Martin.
Last updated: